MediPharm Labs (TSE:LABS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MediPharm Labs is selling its Napanee facility to Kensana Health for $5.5 million, forming a strategic partnership to enhance their manufacturing capabilities and support future growth. This move aligns with MediPharm’s strategy to streamline operations and maximize stakeholder value, while Kensana aims to advance its phytopharmaceutical development. The deal is expected to close by January 1, 2025.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
